Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Sold by Guggenheim Capital LLC

Guggenheim Capital LLC lessened its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 67.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 68,941 shares of the real estate investment trust's stock after selling 143,382 shares during the period. Guggenheim Capital LLC's holdings in Sabra Health Care REIT were worth $1,194,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. XTX Topco Ltd acquired a new stake in shares of Sabra Health Care REIT in the fourth quarter worth approximately $557,000. Mariner LLC purchased a new position in Sabra Health Care REIT in the 4th quarter valued at $194,000. Barclays PLC boosted its stake in Sabra Health Care REIT by 109.4% during the 4th quarter. Barclays PLC now owns 1,420,356 shares of the real estate investment trust's stock worth $24,601,000 after purchasing an additional 741,959 shares during the last quarter. Summit Investment Advisors Inc. grew its holdings in shares of Sabra Health Care REIT by 2.3% during the fourth quarter. Summit Investment Advisors Inc. now owns 72,806 shares of the real estate investment trust's stock worth $1,261,000 after buying an additional 1,641 shares in the last quarter. Finally, Rockefeller Capital Management L.P. raised its position in shares of Sabra Health Care REIT by 9.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 16,890 shares of the real estate investment trust's stock valued at $293,000 after buying an additional 1,521 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Health Care REIT Stock Performance

SBRA traded down $0.08 during trading on Friday, hitting $17.42. 2,009,689 shares of the stock were exchanged, compared to its average volume of 2,138,271. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. Sabra Health Care REIT, Inc. has a 1-year low of $13.82 and a 1-year high of $20.03. The stock has a fifty day moving average price of $17.14 and a two-hundred day moving average price of $17.52. The firm has a market capitalization of $4.14 billion, a P/E ratio of 32.87, a PEG ratio of 1.97 and a beta of 0.93.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, meeting analysts' consensus estimates of $0.36. The business had revenue of $182.35 million for the quarter, compared to analysts' expectations of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Friday, February 14th were issued a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.89%. Sabra Health Care REIT's dividend payout ratio is currently 226.42%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on SBRA shares. Truist Financial raised their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, March 18th. Citizens Jmp upgraded Sabra Health Care REIT from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, January 7th. Finally, JMP Securities raised Sabra Health Care REIT from a "market perform" rating to an "outperform" rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.33.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.